
The latest thought leadership from our expert teams

With technology innovation, pharma can drive targeted delivery and seize market opportunity
Technology innovations are now able to start realising health concepts that have been talked about for years. As Stephanie Mou explains, insurmountable market advantage awaits the organisation that can establish a compelling delivery platform over the next five years…
- AI & Data Analytics consultancy
- Human factors

Drug delivery implant miniaturisation opens doors for disruptive innovation
What does the future of next generation implantable drug delivery devices look like? Harry Moorman believes a CC concept breakthrough in smart, miniaturised active implant innovation offers significant opportunity for a market that is ripe for development and commercial growth…
- Digital health
- Human factors
- Industrial design
- User Experience (UX)

Powering the future of implantable medical devices
One of the major questions to address when designing a new implantable medical device is how best to power it. Drawing on his extensive knowledge of the field, medical device development expert Neil Rosewell has identified the top six issues around smart implant power that developers need to bear in mind right now…
- Digital health
- Electronics & ASICs
- Sensing
- User Experience (UX)

Quantum computing for pharma and life sciences – opportunities are on the horizon
What can quantum computing and quantum technology do for the pharma and life sciences industry? After reviewing the latest signs of quantum innovation in practice across Europe, Elizabeth Thomas has conferred with Cambridge Consultants’ quantum experts and now shares her insights into how organisations can start implementing an action plan…
- AI & Data Analytics consultancy
- Physical sciences
- Strategic advice
- Synthetic biology

What next for precision medicine?
The world of DNA testing is changing fast and the race is on to provide cheap, quick genetic diagnoses for patients. So what are the opportunities for companies working in this dynamic field?
- AI & Data Analytics consultancy
- Cell and gene therapy

Six innovative Asia medtech start-ups to watch
Asia’s medical technology market is predicted to account for a third of global medical technology sales by 2025. As such, it's a hotbed for start-ups, so here are our six innovative start-ups to watch that are part of this year’s MedTech Innovator cohort.
- Bioinnovation
- Cell and gene therapy
- Digital health
- Innovation management
- User Experience (UX)

Celebrating award-winning design innovation in an underserved area of women’s health
The design and technology teams working in medical technology innovation at Cambridge Consultants are passionate about improving women’s healthcare. We were delighted to welcome to CC Aashi Srivastava, the winner of Cambridge Consultants ‘Excellence in Breakthrough Design’ at the New Designers award ceremony to hear more about her perineal tear recovery kit to aid new Mums.
- Digital health
- Human factors
- Industrial design
- User Experience (UX)

Collaboration is the key to unlocking a successful connected future for global pharma
Global pharma is hitting a major fork in the road, and one way leads to failure. For me, it’s vital that the industry comes together to grasp the once-in-a-generation opportunity that emergent technology is offering.
- Bioinnovation
- Digital health
- Human factors
- User Experience (UX)

Start-up technology can be risky business if threats aren’t tackled hard and early
Founders of early-stage start-ups are characteristically passionate, driven and optimistic. Understandably so. Very often they are nurturing a breakthrough idea with the capacity to disrupt business and change the world for the better. So, as they embark on the mission to sell their vision, they should accentuate the positive and keep negative thoughts of risk to the back of their mind, right? Wrong.
- AI & Data Analytics consultancy
- Bioinnovation
- Cell and gene therapy
- Connectivity & IoT
- Innovation management
- Project management
- Robotics
- Strategic advice
- Sustainability
- Synthetic biology

MedTech Innovator is not a one-off, start-up nurturing is in our DNA
Yan Lin Lye and a team from CC are embarking on a sequence of mentoring sessions as part of our commitment to MedTech Innovator Asia Pacific. For the second consecutive year, we're collaborating with the organisation to provide hands-on professional support to selected start-up participants.
- Bioinnovation
- Cell and gene therapy
- Strategic advice
- Synthetic biology

Our synthetic vision of affordable and accessible cell therapy for all
The emergence of cell-based therapy's is one of the most important human stories of our time. Read our synthetic vision of affordable and accessible cell therapy for all...
- Bioinnovation

Why digital biomarkers are vital for a patient-empowering connected health future
The pandemic has accelerated our path towards an inevitable conclusion – a digitally connected healthcare future that empowers both patients and carers alike. The opportunities are out there, so what’s the next step for pharma companies and device developers with ambitions in the space?
- Digital health